Arkolith/Insider Trading/CNTX/Form 4

Lehr Martin A.

Chief Executive Officer, DirectorContext Therapeutics Inc. (CNTX) · full profile →Form 4 · filed Feb 25, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2022Grant(A)254K—$0254K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001842952-22-000018) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML